Hybrid polymers, pharmaceutical compositions and methods of synthesizing the same
申请人:Kirshenbaum Kent
公开号:US09458449B2
公开(公告)日:2016-10-04
Novel hybrid polymers are disclosed that have a structure represented by the following
wherein Abiotic oligomer, Polypeptide, X, Y, and R1 are as described herein. The methods to prepare the hybrid polymers via novel oxazolidinyl compounds are also described.
HYBRID POLYMERS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF SYNTHESIZING THE SAME
申请人:Kirshenbaum Kent
公开号:US20150044189A1
公开(公告)日:2015-02-12
Novel hybrid polymers are disclosed that have a structure represented by the following
wherein Abiotic oligomer, Polypeptide, X, Y, and R
1
are as described herein. The methods to prepare the hybrid polymers via novel oxazolidinyl compounds are also described.
US9458449B2
申请人:——
公开号:US9458449B2
公开(公告)日:2016-10-04
Chemoselective fragment condensation between peptide and peptidomimetic oligomers
作者:Paul M. Levine、Timothy W. Craven、Richard Bonneau、Kent Kirshenbaum
DOI:10.1039/c3ob40606g
日期:——
We report the first example of chemoselective fragment condensation, through native amide bond formation, between peptoid and peptide oligomers. Peptoid oligomers bearing C-terminal salicylaldehyde esters were synthesized and ligated to peptides containing N-terminal serine or threonine residues. We investigate the ligation efficiency of peptoid oligomers varying in length, sequence, and C-terminal